NEW YORK (GenomeWeb News) – Febit said today that it will collaborate with the Translational Genomics Research Institute to evaluate the use of Febit’s Geniom microarray technology in capturing DNA for next-generation sequencers.
TGen is Febit’s first US pilot user for the HybSelect technology, which the company said enables selective DNA capture and elution in order to pre-select sequences for next-generation platforms.
Febit President Cord Staehler in a statement said the TGen study will provide “important data” that will help the company prepare to launch the HybSelect in early 2009.
HybSelect is based on Febit's Geniom technology and uses arrays within microfludic biochips to select targeted regions of DNA for sequencing. The company said that the Geniom biochips are “programmable” and can contain “any desired set of capture probes.”